A Winnipeg biotech company is being celebrated for its role in a first-of-its-kind treatment in Canada.
It’s called phage therapy and it was used to treat a serious resistant infection.
“Bacteria phages are actually viruses that only infect bacteria. So they don’t infect human cells, animal cells, or event plant cells,” said Dr. Steven Theriault, the CEO of Cytophage Technologies.
The therapy is antimicrobial and works where other medications do not. Cytophage is at the forefront of research and development.
“We’re a team of scientists that are synthetic biologists as well as trained virologists or people that work on viruses. And what we do is we unlock the potential of bacteria phages.
Theriault said there are many types of bacteria phage but noted the one his company works is like a lunar lander.
“If you can think of it as landing on the mood, it would be landing on a …